Axsome Therapeutics, Inc. Annual Cost of Revenue in USD for 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Axsome Therapeutics, Inc. annual/quarterly Cost of Revenue history and growth rate for 2022.
  • Axsome Therapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2022 was $1.9M.
Cost of Revenue, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $5.2M Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.